SCHEMBL4833939

SCHEMBL4833939

O=C1C2CC3C(=O)N(OS(=O)(=O)Cc4ccccc4)C(=O)C3CC2C(=O)N1OS(=O)(=O)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
TSHR P16473 2/20 0.39
HPGD P15428 2/20 0.39
FAAH O00519 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
ELANE P08246 1/20 0.39
PRTN3 P24158 1/20 0.39
PRSS3 P35030 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 4/20 0.38
HTT P42858 1/20 0.38
CTSG P08311 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PARL Q9H300 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829686 0.85 KMT2A (0.50) KMT2ATSHRHPGDFAAHPRSS1
SCHEMBL1606492 0.80 PARL (0.59) KMT2ATSHRHPGDFAAHPRSS1
SCHEMBL4829782 0.79 KMT2A (0.45) KMT2ATSHRHPGDFAAHPRSS1
SCHEMBL4837033 0.77 PARL (0.64) KMT2AHPGDALDH1A1HTTNPC1
SCHEMBL5552404 0.77 MAPT (0.57) KMT2AHPGDFAAHPRSS1PRSS2
SCHEMBL30964011 0.77 MAPT (0.57) KMT2AHPGDFAAHPRSS1PRSS2
SCHEMBL28448540 0.74 KMT2A (0.46) KMT2ATSHRHPGDFAAHPRSS1
SCHEMBL19999237 0.70 ALDH1A1 (0.63) KMT2AHPGDCA1CA2CA9
SCHEMBL14422308 0.69 KMT2A (0.61) KMT2ATSHRHPGDFAAHPRSS1
SCHEMBL6114729 0.69 KMT2A (0.61) KMT2ATSHRHPGDFAAHPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 KMT2A 1016/4885TSHR 3884/4885HPGD 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.